Clinical trial

Adversity and Its Association With the Development and Expression of Rheumatic Diseases

NCT06386380

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2024-06-01

PhaseN/A

Study timeline

Study start (estimated)2024-06-01Date precision: day

Registry last updated2024-05-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

RhA - Rheumatoid Arthritisunresolved

Interventions

Rheumatic diseases Mistreatment Scale (RDMS)OTHER

Routine assessment of patient index data 3 (RAPID-3)OTHER

Health Assessment Questionnaire (HAQ)OTHER

WHOQOL-BREFOTHER

Depression, Anxiety and Stress Scale (DASS-21)OTHER

Brief Resilient Coping ScaleOTHER

Expression of CDKN2A /p16INK4aGENETIC

Immunophenotype of leukocyte subpopulationsOTHER

Telomere lengthGENETIC

Cellular senescenceOTHER

Sponsors & collaborators

National Institute of Medical Sciences and Nutrition, Salvador Zubiranlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06386380 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.